• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Liposomal codelivery of inflammation inhibitor and collagen protector to the plaque for effective anti-atherosclerosis

    2023-03-14 06:52:14XiaotongLiJiayiGuQingqingXiaoYingLiuPingZhouLifangFanXiulianZhangXiangLuJunWuZhngxiaLiuWi
    Chinese Chemical Letters 2023年1期

    Xiaotong Li,Jiayi Gu,Qingqing Xiao,Ying Liu,Ping Zhou,Lifang Fan,Xiulian Zhang,Xiang Lu,g,Jun Wu,Zhngxia Liu,**,Wi H

    a School of Pharmacy,China Pharmaceutical University,Nanjing 211198,China

    b Department of Geriatrics,The Second Affiliated Hospital,Nanjing Medical University,Nanjing 210011,China

    c Key Laboratory for Aging & Disease,Nanjing Medical University,Nanjing 210011,China

    d Jiangsu Aosaikang Pharmaceutical Co.,Ltd.,Nanjing 211112,China

    e Department of Respiratory Disease,Baoshan Branch,Shuguang Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200120,China

    f Department of Geriatric Cardiology,Jiangsu Provincial Key Laboratory of Geriatrics,The First Affiliated Hospital of Nanjing Medical University,Nanjing 210029,China

    g Department of Geriatrics,The Affiliated Sir Run Run Hospital of Nanjing Medical University,Nanjing 211166,China

    Keywords:Atherosclerosis Plaque Inflammation Collagen Macrophages Co-delivery Liposomes

    ABSTRACT Plaque plays a central role in atherosclerosis (AS) progression,whereas inflammation and destruction of the plaque microenvironment contribute to plaque advancement.As a result,a therapy regime,which combines anti-inflammation and inhibition-degradation of plaque matrix,appears to be a promising strategy to combat AS.Herein,we report a pH-sensitive liposome co-loading with the anti-inflammatory agent(oridonin,ORD) and plaque-collagen protector (marimastat) for anti-AS therapy.ORD was first conjugated with hyaluronic acid (HA) to target the inflammation contributor,pro-inflammatory macrophages.Then,the conjugate assembled onto the MATT-loaded liposomes.The co-loaded system (~150 nm) significantly improved pharmacokinetics over the liposomes without anchoring the conjugate and accumulated effectively in the plaque.The preparation administration allowed efficient anti-AS activities in high-fat diet(HFD)-Apoe-/- mice by decreasing the pro-inflammatory cytokine expression in the serum,lessening the lesion area,alleviating the plaque collagen degradation,promoting macrophage polarization from phenotypic M1 to M2,reducing T helper (Th) 17 cells (Th17)/T regulatory cells (Tregs) and Th1/Th2 ratio, etc.Furthermore,the serum determination in AS patients demonstrated high expression of the inflammatory cytokines,indicating our finding may offer a potential guideline for clinical practice.

    Atherosclerosis (AS) is a chronic inflammatory disease characterized by plaque buildup at the arterial subendothelial space primarily owing to the deposition of activated cells such as macrophages and endothelial cells,lipid and extracellular matrixlike collagen,and glycosaminoglycan [1–4].Clinically,the rupture of the plaque frequently leads to severe cardiovascular events,such as acute myocardial infarction (AMI),stroke,and peripheral arterial disease [5],accounting for 30% of cardiac death worldwide[6].Statin therapy for lipid-lowering is the most commonly used for AS treatment [7,8].However,this regimen has a modest effect on plaque progression [9],and inversely,may increase the risk of coronary heart disease [10].

    Constant inflammation reaction is a vital determinant of plaque development [11].Whereas macrophages,the most abundant leukocytes in the plaque,significantly contribute to inflammation responseviathe production of pro-inflammatory cytokines [12].Unfortunately,single anti-inflammation therapy remains not reduce AS patient mortality [13].Furthermore,the degradation of extracellular plaque-matrix,which disrupts the plaque microenvironment,is another essential factor in promoting plaque advancement[14,15].Collagen constitutes a central portion of the plaque matrix and forms a structural framework under the fibrous cap [16].Viaproviding strength and integrity for the fibrous cap,collagen can protect the plaque from breakup [17].Accordingly,a combined regimen to inhibit decomposition of plaque collagen and suppress inflammationviatargeting plaque macrophages appears to be a promising approach for plaque stabilization.

    Fig.1.Preparation and characterization.(A) Iillustration of the co-loaded pHSLs preparation.(B) Influence of HA-ORD/lipid mass ratio on the pHSLs diameter.(C) FRET between FITC-HA-ORD/Rho-pHSLs with different FITC and Rho mass ratios (excitation wavelength: 430 nm).The HA-ORD was conjugated with FITC,and Rho was loaded in the pHSLs cores.(D) TEM examination.

    Liposomes have been widely used as drug carriers to improve drug delivery due to their various benefits.These include increasing stability through encapsulation,increasing drug efficacy and therapeutic index,improving pharmacokinetic effects (i.e.,decrease elimination and increase circulation lifetime),and reducing the toxicity of encapsulated agents [18,19].This study developed a pH-sensitive liposomal system to co-deliver an anti-inflammatory drug (oridonin,ORD) and a plaque-collagen protector (marimastat,MATT) to the plaque.Briefly,ORD is an anti-inflammatory compound with poor water solubility [20].To improve its solubility and target macrophages,ORD was modified with hyaluronic acid (HA).The HA in the conjugate (HA-ORD) could target cell CD44 receptors [21].MATT,a water-soluble compound,is an effective protector of collagen [22],and MATT could inhibit plaque-collagen degradation by matrix metalloproteinases (MMPs) [23].The pH-sensitive co-delivery liposomes,termed co-loaded pHSLs,were prepared by encapsulating the collagen protector into the aqueous cores and anchoring the conjugate onto the liposomes (Fig.1A).The plaque has an over-metabolism and the resultant acidic microenvironment[24].We proposed that the co-loaded pHSLs could release the two therapeutics in response to the acidic microenvironment after accumulating in the plaque,thereby achieving efficient anti-AS therapy.To obtain proof of concept,we conducted various experimentsin vitroandin vivo.Apoe-/-mice fed with a high-fat diet (HFD)were utilized as a model in the anti-AS studyin vivo.

    The pH-sensitive co-delivery liposomes (co-loaded pHSLs) were prepared by assembling the conjugate HA-ORD onto the MATTloaded pH-sensitive liposomes (MATT-pHSLs) (Fig.1A).First,the targeted conjugate hyaluronic acid-oridonin (HA-ORD) was synthesizedviacondensation reaction.The synthesis of HA-ORD was characterized by1H and13C NMR spectra.Consequently,approximately 70% of fed ORD was linked to HA.Five ORD molecules were involved in one conjugate.MATT-pHSLs were prepared by the film dispersion method and had a diameter of 100–120 nm.Then,the co-loaded pHSLs were prepared by anchoring the hydrophobic section of conjugate onto the liposomesviahydrophobic interactions under ultrasonic conditions.As shown in Fig.1B,the increased proportion of HA-ORD/lipid (w/w) increased the particle size of co-loaded pHSLs from 90 nm to 130 nm.To verify the conjugate loading onto the liposomes,we performed the FRET test by labeling the conjugate with the fluorescence donor (FITC) and encapsulating the fluorescence acceptor (Rho) in the cores of liposomes.As a result of an increase in the mass ratio of FITC/Rho,the maximum intensity of the fluorescence acceptor (Rho) at 575 nm rises gradually,whereas the maximal fluorescence intensity of the donor (FITC) at 515 nm declines (Fig.1C).The results demonstrated the happening of the FRET effect.FRET is always utilized to explore the interaction between two materials by tagging fluorescent donors and acceptors to them [25–27].These results implied the co-assembly of the conjugate and the liposomes.TEM examination displayed the co-loaded pHSLs have a spherical morphology with a 150 nm diameter (Fig.1D).The incubation in 10% serum for 6 h imposed little change on the particle size of MATT-pHSLs and co-loaded pHSLs and,therefore,indicated potential stability in the blood after intravenous injection (Fig.S1 in Supporting information).In addition,little FRET effect between the 6 h incubation liposomes and 0 h incubation samples,implying the two payloads were loaded in the liposomes after serum incubation (Fig.S2 in Supporting information).HPLC assay demonstrated that total drugloading in the co-loaded pHSLs was 8.27% ± 0.19%,wherein the MATT loading was 2.35% ± 0.20% with an encapsulation efficiency of 72.78% ± 6.27%,and while the ORD loading was 6.06%,respectively.After 24 h incubation in 10% serum,the remaining drugs(%) were 98.68% MATT and 99.85% ORD in the co-loaded pHSLs compared with the initial drug loading,demonstrating little drug leakage.The release study depicted that the release of MATT and HA-ORD conjugate from the liposomes at pH 6.0 in first 1 h period was significantly greater than that at pH 7.4 (Fig.S3 in Supporting information,P<0.05),thereby verified the pH-sensitive characteristics of the liposomes.

    To study anti-ASin vitro,we performed various experiments,including M1-like macrophage-targeting,uptake of ox-LDL in macrophages and inflammation inhibition.The accumulation of pro-inflammatory macrophages (M1-like phenotype) promotes the AS pathological process [28].We expected that delivering the targeted anti-inflammatory agent,HA-ORD,to the M1-like macrophages could retard plaque progression through regression of ox-LDL uptake and inflammation activity.First,the targeted uptake of HA-ORD by M1-like macrophages induced by LPS was assayed.The CD44 expression on the M1-like macrophages was verified by confocal imaging after staining with the FITC-CD44 antibody(Fig.S4 in Supporting information).To study the conjugate target ability to the CD44 receptor,we saturated the receptor on the M1-like macrophages by incubation with a high HA-concentration.As shown in Figs.S5A and B (Supporting information),the Rho-HA-ORD uptake in the HA-saturated cells declined significantly(P<0.01).Furthermore,the uptake in the M1-like macrophages was significantly higher than that in nonpolarized RAW264.7(Figs.S5C and D in Supporting information).In addition,the M1-like macrophages uptake was time-related and reached maximal internalization at 2 h post-incubation (Fig.S6 in Supporting information).Overall,the data implied that the conjugate (HA-ORD)could target M1-like macrophages.

    The excessive influx of ox-LDL facilitates the formation of the foam cells and then induces the development of plaques [29].Accordingly,the inhibition of ox-LDL uptake in macrophages functionally impedes AS progress and promotes plaque stability [30,31].As depicted in Figs.S7A and B (Supporting information),the M1-macrophages (LPS-induced RAW264.7) possess improved ability to take up ox-LDL over the nonpolarized RAW264.7 without LPStreatment (Figs.S7A and B,Fig.S8 in Supporting information).The treatment with co-loaded pHSLs restrained the ox-LDL influx with higher efficacy than the incubation with other formulations(Fig.S7B,P<0.001).Furthermore,the anti-inflammatory study indicated that HA-ORD-containing formulations,HA-ORD and coloaded pHSLs,reduced the production of inflammatory cytokines,IL-6 and TNF-α(Figs.S7C and D in Supporting information),while co-loaded pHSLs allowed enhanced anti-inflammation effect.These results demonstrated that co-loaded pHSLs could alleviate ASin vitro.

    Next,we investigated anti-AS efficacyin vivoin theApoe-/-mice with HFD feedviaassaying plaque volume and blood lipid level.After 4 weeks of HFD feeding,theApoe-/-mice were intravenously administrated with different formulations every five days for 8 weeks (Fig.S9A in Supporting information).We first stained descending aorta with oil-red-O (ORO) to assay the lesion area after treatment.As displayed in Figs.S9B and C (Supporting information),combination treatment with the physical mixture or the co-loaded pHSLs reduced the lesion area in the descending aorta compared with the single treatment of free MATT or HA-ORD(P<0.01).Significantly,the dosing of co-loaded pHSLs at low and high doses rendered 0.5 (P<0.05) and 1-fold decrease (P<0.01)in the lesion area over the single administration.Next,we determined the plaque area by staining the aortic sinus cryosection with H&E and ORO (Figs.S9D and E in Supporting information).As showed in H&E and ORO staining,the lesions were inhibited after therapy.The plaque area in the group treated with the co-loaded pHSLs was reduced compared with the groups dosed with the PBS,free HA-ORD,or physical mixture of MATT and HA-ORD (Fig.S9D).The semi-quantitative analysis indicated that the plaque area in groups dosed with PBS,free MATT,free HA-ORD,physical mixture,co-loaded pHSLs at low and high doses was 32.34% ± 1.96%,31.77% ± 0.63%,26.10% ± 3.30%,25.20% ± 2.40%,17.33% ± 4.72%and 12.34% ± 2.11%,respectively (Fig.S9E).The treatment with the co-loaded pHSLs enabled a 1–1.5-fold plaque-area decrease over the PBS treatment.In addition,the mouse weight usually increased during the treatment duration.As a result,no apparent pathologic change after treatment was observed by H&E staining,indicating the safety of these formulations (Figs.S9F and S10 in Supporting information).Overall,the results demonstrated that the therapy with the co-loaded pHSLs could impede plaque advancement effectively.

    Blood lipid is a significant factor contributing to AS progression,including low-density lipoproteins (LDL),cholesterol,high-density lipoproteins (HDL) cholesterol,and other components [32].As reported,the HDL protected the HFD diet animals from AS and,inversely,the LDL is a kind of “bad” cholesterol that its accumulation accelerates the development of AS [33,34].First,we determined the blood lipid levels after dosing.The treatment with the co-loaded pHSLs lowered the serum LDL and total cholesterol(TC) compared with PBS-treatment (P<0.05),accompanied with a modest effect on triglyceride (TG) and HDL (Figs.S11A–D in Supporting information).Next,we calculated the plasma TG/HDL ratio and atherogenic index (common logarithm of TC/HDL ratio).The treatment with co-loaded pHSLs reduced the ratio of TG/HDL and the atherogenic index compared with PBS treatment (Figs.S11E and F in Supporting information,P<0.05).The increase in the TG/HDL ratio and atherogenic index indicates AS exacerbation and a growing risk of cardiovascular events [35].As a result,the coloaded pHSLs administration is promising to attenuate AS by lowering the lipid levels.

    To investigate the contributors to the effective anti-AS effi-cacy,we next studied the pharmacokinetics of co-loaded pHSLs and explored their targetability to the active axis of plaquemicroenvironment components (macrophages and collagen)-inflammatory factors.

    Blood circulation is an essential factor that governs the accumulation of drug carriers in the target site of interest [36,37].And the fluorescence dye was widely used to quantify the pharmacokinetics of carriers,especially the environment-responsive dye,such as aggregation-caused quenching (ACQ) probe [38,39].Furthermore,previous reports demonstrated that the carrier circulation performance obtained by determining the drug was generally similar to fluorescence-dye determination [40].As depicted in Fig.2A,the DiR labeled co-loaded pHSLs displayed significantly higher plasma concentrations at each time point post-injection than DiR-pHSLs without anchoring of HA-ORD.Next,the pharmacokinetic parameters were calculated based plasma concentration(Table S1 in Supporting information).The co-loaded pHSLs demonstrated prolongedt1/2of blood circulation and mean residence time (P<0.05),increased AUC (P<0.05),and lowered clearance rate (CL,P<0.05) in contrast to pHSLs.Therefore,the data indicated that the conjugate (HA-ORD) anchoring enabled prolonged blood circulation time and improved pharmacokinetics.The improved performancein vivoof co-loaded pHSLs may be because the surface HA could offer an extra energy barrier for nanoparticles by presenting bound water molecules and compromising the absorption of opsonin [41,42].

    Then,we first studied the plaque-targeted ability of CF-labeled co-loaded pHSLs in theApoe-/-HFD model.As well known,numerous M1-like macrophages inhabit inside the plaque [43].Accordingly,the plaque targeting was characterized by co-localizing the CF-labeled pHSLs with the M1-like macrophages marked by Cy3 for CD68.As shown in Fig.2B,profound yellow fluorescent spots were exhibited in the group dosed with the CF-labeled pHSLs or co-loaded pHSLs; in contrast,slight yellow fluorescence was observed in the group treated with free dye.Importantly,coloaded pHSLs have more profound co-localization compared with CF-labeled pHSLs.The results demonstrated that the co-loaded pHSLs with HA-ORD anchoring effectively accumulated at the plaque and located inside the lesion area.

    Collagen,a significant component of the plaque extracellular matrix,is critical to stabilizing the plaque and preventing rupture [44].The higher the collagen content,the more stable the plaque [45].Herein,the collagen was identified by Masson staining.As shown in the Masson staining (Fig.2C),the positive collagen stained in blue was demonstrated in the groups treated with MATT-loading preparations,especially with co-loaded pHSLs at low or high doses.Quantified assay indicated that the treatment with co-loaded pHSLs allowed a 1–1.5-fold increase of collagen expression compared to PBS treatment (Fig.2D,P<0.01).Furthermore,co-loaded pHSLs (high dose) demonstrated elevated collagen expression compared to the physical mixture (P<0.05).These results verified that the co-loaded pHSLs could alleviate the plaquecollagen degradation and,therefore,is promising to protect the plaque from disruption.

    To study macrophage polarization switch,we first assayed the polarization pattern of macrophages in the plaque inApoe-/-HFD model after treatment.As depicted in the result of confocal imaging (Fig.3A),a large amount of red fluorescent spots (marking CD68+) and slight green fluorescence (marking CD206+) appeared in the PBS group.Conversely,we observed fewer red fluorescent spots and considerable green fluorescence in the groups administered with HA-ORD loading preparations.Notably,coloaded pHSLs demonstrated elevated green fluorescence intensity compared to the physical mixture (PM) and other preparations.Additional quantified assay indicated that the ratio of CD68+/CD206+macrophages from the groups administered with co-loaded pHSLs at the low or high dose displayed approximately 80% and 40% reduction compared with the PBS- and PMtreated groups,respectively (Fig.3B,P<0.001 andP<0.05).To confirm the phenotype switch of macrophages,we also assayed the M1/M2-like subset in the liver after treatment.The administration of co-loaded pHSLs did not affect the total number of liver macrophages as compared with PBS (Figs.S12A and B in Supporting information),whereas the administration resulted in the expansion of CD206+ macrophages and reduction of CD68+phenotype (Figs.S12C and D in Supporting information,P<0.05).

    Fig.2.Pharmacokinetics,plaque targeting and collagen in the lesion area.(A) Pharmacokinetics of pHSLs and co-loaded pHSLs.DiR labeled formulations were intravenously injected at a DiR dose of 5 mg/kg,according to the body weight.The fluorescence intensity was detected by a microplate reader at 748 nm (excitation) and 780 nm(emission). n=5.(B) Targeting the plaque in Apoe-/- HFD mice.The tricuspid ring of the mouse heart was isolated for sectioning after 2 h injection with CF-labeled formulations and the control (free CF) via the tail vein at a CF dose of 2.5 mg/kg,according to the body weight.The plaque was marked by labeling the CD68 on macrophages with Cy3 (red,5 μg/mL).Scale bar: 50 μm.(C) Masson staining of the descending aortas after administration.The collagen fibers were stained to blue and muscle fibers to red.The plaque was stained to red.The dosage of ORD and MATT in the pHSLs was 5/5 mg/kg and 5/10 mg/kg for low dose and high dose,respectively.(D) Semi-quantitative of collagen in the plaque calculated by ImageJ.pHSLs herein were the co-loaded pHSLs.Scale bar: 200 μm. n=3,*P<0.05,**P<0.01,compared with saline; #P<0.05,compared with free MATT; ns,not significant.

    Fig.3.Targeting macrophages and ameliorating inflammation.(A) Analysis of macrophages by immunofluorescence staining and (B) semi-quantitative of the M1/M2 ratio by ImageJ.M1 macrophages (CD68) were stained to red with Cy3-labeled second antibody,and M2 macrophages (CD206) were stained to green with FITC-labeled second antibody.Scale bar: 20 μm.(C–E) The inflammatory cytokines expression in the serum.IL-6 and TNF-α were measured using the Bio-Plex? multiplex array systems.IL-22 was determined with ELISA kits.The dosage for ORD and MATT was 5 mg/kg.The low dose and high dose indicate the different dosages of co-loaded pHSLs,5/5 mg/kg and 5/10 mg/kg for ORD and MATT. n=3,*P<0.05,**P<0.01,***P<0.001,compared with saline; #P<0.05,##P<0.01,compared with free HA-ORD,free MATT or physical mixture; ns,not significant.

    In addition,we detected the immune cells,T regulatory cells(Tregs) and T-lymphocyte helper (Th) cells,in the serum,owing to that Tregs could inhibit inflammation and AS progression,while the increased ratio of Th17/Tregs and Th1/Th2 always exacerbate inflammation and atherogenesis [46–48].As displayed in Figs.S13A–D (Supporting information),dosing the co-loaded pHSLs at low or high dose demonstrated limited influence on the Treg percent and,while reducing the ratio of Th17/Tregs (P<0.05)and Th1/Th2 (P<0.01) compared with PBS administration.Overall,the data revealed the treatment with co-loaded pHSLs regressed macrophage polarization switch towards pro-inflammatory phenotype in the plaque and livers and decreased the ratio of Th1/Tregs and Th1/Th2,which could benefit the plaque stabilization [49].

    Finally,the inflammatory serum cytokines were measured after treatment.The pro-inflammatory factors,IL-6,IL-22,and TNFα,were significantly downregulated after treatment with HA-ORD loading preparations,including free HA-ORD,PM,and co-loaded pHSLs,compared with PBS treatment (Figs.3C–E,P<0.001).Especially,the dosing of co-loaded pHSLs at a high dose reduced the levels of IL-6 and IL-22 by 3- and 1.5-fold,respectively,over PM treatment (Figs.3C–E).The data implied that the treatment with co-loaded pHSLs could lessen the inflammation.

    To confirm the present results that might provide potential guidelines for the clinical treatment,we further tested the serum cytokines in patients with acute myocardial infarction (AMI)caused by the rupture of AS plaque [50] and healthy volunteers without cardiovascular disease.The population baseline table is shown in Table S2 (Supporting information).As displayed in Fig.S14 (Supporting information),elevated inflammatory cytokines,IL-6,IL-22,and TNF-α,were demonstrated in the patients compared with the healthy volunteers (P<0.001).The data indicated that our results could be translated into the clinic practices of AS therapy.

    Taken together,we proved that the co-loaded pHSLs had extended blood circulation time,effectively accumulated in the plaque,facilitated macrophage polarization into M2-like phenotype,and rendered inhibition of both inflammation and collagen degradation (Fig.S15 in Supporting information).Furthermore,their administration to HFD-Apoe-/-mice reduced the lesion area,elevated the percent of Tregs,decreased the Th1/Th2 ratio.Targeted co-delivery of inflammation inhibitor and collagen protector to the plaque represents a promising approach for anti-AS therapy.

    The anchoring strategy developed here acts as a promising approach to load a polymer-based conjugate/prodrug in liposomes to improve delivery.The conjugate HA-ORD with a molecular weight of over 10,000 Da is challenging to be loaded in liposome core or lipid bilayer.Rather than loading the conjugate at the two locations,we loaded it on liposomes by the anchoring strategy that the hydrophobic section in conjugate inserted into the liposome’s lipid membrane.Furthermore,the anchoring improved the pharmacokinetic performance of the pHSLs.In addition,the anchoring facilitated plaque accumulation of the co-loaded pHSLs because HA on the co-loaded pHSLs could target the CD44 receptors that are overexpressed on the cells inhabiting the plaques.The CD44 receptors in the plaque have>10-fold increase over that in healthy vascular tissue [51].Nonetheless,the plaque targeting-efficacy of drug delivery systems is correlated with plaque advancement [52].Additional study is needed to clarify the targetability of the co-loaded pHSLs to the early and advanced plaque.

    The features,including thin fibrous cap,inflammation,accumulation of inflammatory cells,and raised blood lipid levels are closely linked to the rupture of the plaque [53].Significantly,the loss of fibrillar collagen is a direct cause to make the fibrous cap become thinning [54].In this study,we found that the targeting co-delivery of the collagen protector MATT and antiinflammatory HA-ORD conjugate using pHSLs to the plaque relieved the degradation of plaque collagen,reduced the accumulation of M1-like macrophages,alleviated inflammation,and declined the blood level.These indicators confirmed that the coloaded pHSLs could stabilize the rupture-prone plaque in HFDApoe-/-mice.Furthermore,we found that the plaque was regressed,as evidenced by dosing the co-loaded pHSLs to HFDApoe-/-mice reduced the plaque area by 1–1.5-fold compared to the PBS treatment.The plaque regression may be ascribed to the lowering of blood lipids,LDL and TC,and reduced residence of proinflammatory macrophages after administration of co-loaded pHSLs [55].

    IL-6 plays a leading role in the inflammatory progressions underlying cardiovascular diseases [28,56],and meanwhile,TNF-αfacilitates the development of plaque at all stages [12,57].Herein,we demonstrated that treatment with the co-loaded pHSLs significantly reduced the IL-6,IL-22,and TNF-αin HFD-Apoe-/-mice(Figs.3C–E).The data is consistent with the serum determination from the AS patients,in which the two indicators markedly upregulated,as displayed in Fig.S14.As a result,our data may inspire the clinic treatment of AS,which is combinatorial use of antiinflammatory drugs and collagen protectors to improve AS therapy.

    In summary,the co-loaded pHSLs allowed effective anti-AS therapy by targeted co-delivery of the anti-inflammatory (HA-ORD)and collagen protector (MATT) to the plaque.Moreover,the targeted co-delivery suppressed plaque regression.Besides promoting macrophage polarization into M2-like phenotype and alleviating inflammation and plaque-collagen degradation,we confirmed that the co-delivery could lower the blood lipid level and modulate the immune-cell ratio of Th17/Tregs and Th1/Th2 as well.We believe the current liposomal strategy is promising to target the AS plaque.Targeted co-delivery of anti-inflammatory drugs and collagen protectors to the plaque represents an efficient regimen to treat AS.The finding may provide a potential guideline for the clinic practices of AS treatment.

    MATT utilized in the study was a broad-spectrum MMP inhibitor and was not approved for clinical use.However,Periostat,an MMP inhibitor,has been permitted clinically [58].Accordingly,the combinatorial use of an anti-inflammatory drug and Periostat has the potential as an AS therapy regimen.

    Declaration of competing interest

    The authors have no conflicts of interest to declare.

    Acknowledgments

    This study was supported by the National Natural Science Foundation of China (Nos.81872823,82073782,81970374),the Shanghai Science and Technology Committee (No.19430741500).We are thankful for the guidance and help provided by Lab Center,the Second Affiliated Hospital of Nanjing Medical University.

    Supplementary materials

    Supplementary material associated with this article can be found,in the online version,at doi:10.1016/j.cclet.2022.04.081.

    亚洲精品成人av观看孕妇| 久久精品熟女亚洲av麻豆精品| 久久人人97超碰香蕉20202| 新久久久久国产一级毛片| 精品久久久久久久毛片微露脸 | 欧美少妇被猛烈插入视频| 久久久欧美国产精品| 丰满人妻熟妇乱又伦精品不卡| 一区二区三区精品91| 丝瓜视频免费看黄片| 免费看十八禁软件| 天天操日日干夜夜撸| 纵有疾风起免费观看全集完整版| 免费观看av网站的网址| 少妇粗大呻吟视频| 亚洲av成人不卡在线观看播放网 | 亚洲人成77777在线视频| 久久久久久久久免费视频了| 国产成人a∨麻豆精品| 免费少妇av软件| 下体分泌物呈黄色| 2018国产大陆天天弄谢| 国产精品久久久久久精品古装| 午夜福利视频精品| 午夜日韩欧美国产| 国产99久久九九免费精品| 国产成人av激情在线播放| 亚洲欧洲日产国产| 成年女人毛片免费观看观看9 | 久久精品亚洲av国产电影网| 久久午夜综合久久蜜桃| 欧美成人午夜精品| 男女无遮挡免费网站观看| 肉色欧美久久久久久久蜜桃| 日韩大片免费观看网站| www日本在线高清视频| 精品亚洲成国产av| 性色av乱码一区二区三区2| 国产麻豆69| 国产成人免费无遮挡视频| 老汉色∧v一级毛片| kizo精华| 亚洲av国产av综合av卡| 天天操日日干夜夜撸| 中文字幕人妻丝袜一区二区| 久久狼人影院| 韩国精品一区二区三区| 精品久久久久久电影网| 在线观看人妻少妇| 在线观看www视频免费| 啦啦啦啦在线视频资源| 超碰97精品在线观看| 99久久人妻综合| 成年动漫av网址| 国产精品国产av在线观看| 亚洲国产日韩一区二区| 极品人妻少妇av视频| 热re99久久国产66热| 999久久久国产精品视频| 十八禁网站网址无遮挡| 亚洲av成人精品一二三区| 真人做人爱边吃奶动态| 91成人精品电影| 中文字幕人妻丝袜制服| 午夜老司机福利片| 咕卡用的链子| av欧美777| 国产成人精品久久二区二区91| 大码成人一级视频| av不卡在线播放| 久久久久久免费高清国产稀缺| 国产精品免费大片| 久久久久久久国产电影| 一级毛片电影观看| 国产一区二区在线观看av| 午夜av观看不卡| 亚洲欧美一区二区三区黑人| 少妇猛男粗大的猛烈进出视频| 婷婷丁香在线五月| 国产国语露脸激情在线看| 免费不卡黄色视频| 大码成人一级视频| 成人影院久久| 精品少妇黑人巨大在线播放| 国产三级黄色录像| 成人国产av品久久久| 99久久精品国产亚洲精品| 999精品在线视频| 久久久久国产精品人妻一区二区| 在线 av 中文字幕| 国产深夜福利视频在线观看| 国产主播在线观看一区二区 | 亚洲人成电影观看| 超碰成人久久| 婷婷色综合www| 一二三四在线观看免费中文在| 国产高清视频在线播放一区 | 国产无遮挡羞羞视频在线观看| 欧美+亚洲+日韩+国产| 悠悠久久av| 久久亚洲精品不卡| 亚洲人成电影观看| 成年人免费黄色播放视频| 两个人免费观看高清视频| 免费在线观看完整版高清| 精品免费久久久久久久清纯 | 久久鲁丝午夜福利片| 天天添夜夜摸| 国产一区二区三区av在线| 一本色道久久久久久精品综合| 欧美日韩视频高清一区二区三区二| av国产久精品久网站免费入址| 丁香六月天网| 久久天躁狠狠躁夜夜2o2o | 啦啦啦 在线观看视频| 视频在线观看一区二区三区| 午夜免费鲁丝| 国产一区有黄有色的免费视频| 欧美精品一区二区大全| 校园人妻丝袜中文字幕| 天天影视国产精品| 国产黄色免费在线视频| 国产成人av激情在线播放| 久久久久久久国产电影| 成年美女黄网站色视频大全免费| av天堂久久9| 老汉色∧v一级毛片| 国产精品一区二区在线观看99| bbb黄色大片| 一区二区三区乱码不卡18| 日韩视频在线欧美| 久久精品亚洲av国产电影网| 国产免费一区二区三区四区乱码| 精品人妻在线不人妻| 免费高清在线观看视频在线观看| 99久久99久久久精品蜜桃| av在线老鸭窝| 超色免费av| 日本av手机在线免费观看| 自线自在国产av| 欧美激情高清一区二区三区| 青春草亚洲视频在线观看| 黄色 视频免费看| 成人亚洲欧美一区二区av| av又黄又爽大尺度在线免费看| 亚洲精品一卡2卡三卡4卡5卡 | 亚洲九九香蕉| 成人18禁高潮啪啪吃奶动态图| 悠悠久久av| 久久中文字幕一级| 亚洲欧洲日产国产| 飞空精品影院首页| 国产成人精品久久久久久| 男女国产视频网站| 韩国精品一区二区三区| 国产黄色免费在线视频| 精品卡一卡二卡四卡免费| 国产在线观看jvid| 香蕉国产在线看| 午夜91福利影院| 久久精品熟女亚洲av麻豆精品| 一级毛片女人18水好多 | 日韩av在线免费看完整版不卡| 美女主播在线视频| 伦理电影免费视频| 亚洲欧美一区二区三区久久| 亚洲欧美日韩另类电影网站| 免费看av在线观看网站| cao死你这个sao货| 欧美日韩视频精品一区| 看免费av毛片| 自线自在国产av| 80岁老熟妇乱子伦牲交| 侵犯人妻中文字幕一二三四区| 又紧又爽又黄一区二区| 新久久久久国产一级毛片| 亚洲中文av在线| 青草久久国产| 午夜久久久在线观看| 天堂俺去俺来也www色官网| 在线观看一区二区三区激情| 精品人妻在线不人妻| 黑丝袜美女国产一区| 亚洲欧美成人综合另类久久久| 亚洲精品国产av成人精品| 久热这里只有精品99| 美女主播在线视频| 99久久99久久久精品蜜桃| 男女无遮挡免费网站观看| 婷婷色麻豆天堂久久| 国产1区2区3区精品| 在线观看一区二区三区激情| 精品亚洲乱码少妇综合久久| 久久久精品免费免费高清| 久久精品人人爽人人爽视色| 嫁个100分男人电影在线观看 | 国产亚洲av高清不卡| 免费黄频网站在线观看国产| 亚洲,欧美精品.| netflix在线观看网站| 日本欧美国产在线视频| 涩涩av久久男人的天堂| 人体艺术视频欧美日本| 午夜福利在线免费观看网站| 操出白浆在线播放| 亚洲欧洲日产国产| 下体分泌物呈黄色| 男人添女人高潮全过程视频| 男女免费视频国产| 桃花免费在线播放| 在现免费观看毛片| 久久久久久久大尺度免费视频| 中文字幕人妻丝袜制服| 99国产精品一区二区蜜桃av | 国产成人系列免费观看| 午夜av观看不卡| 免费日韩欧美在线观看| 国产精品九九99| 中文精品一卡2卡3卡4更新| 精品国产超薄肉色丝袜足j| 精品国产一区二区三区久久久樱花| svipshipincom国产片| 成人国产一区最新在线观看 | 久久久久久人人人人人| 51午夜福利影视在线观看| 中国国产av一级| 午夜福利视频在线观看免费| 国产精品国产三级国产专区5o| 美女高潮到喷水免费观看| 亚洲av美国av| 电影成人av| 夫妻午夜视频| 侵犯人妻中文字幕一二三四区| av视频免费观看在线观看| 男的添女的下面高潮视频| 人成视频在线观看免费观看| 美女午夜性视频免费| 日韩欧美一区视频在线观看| 你懂的网址亚洲精品在线观看| 精品国产一区二区久久| 人妻人人澡人人爽人人| 在线亚洲精品国产二区图片欧美| 国产精品国产av在线观看| 久久精品成人免费网站| 男女国产视频网站| 日韩 欧美 亚洲 中文字幕| 18禁黄网站禁片午夜丰满| 亚洲一区中文字幕在线| 国产av精品麻豆| 久久国产精品人妻蜜桃| 久久狼人影院| 日韩中文字幕视频在线看片| 好男人电影高清在线观看| 久久久亚洲精品成人影院| 人妻人人澡人人爽人人| 性高湖久久久久久久久免费观看| 91老司机精品| 青春草视频在线免费观看| 亚洲av成人精品一二三区| 国产精品一二三区在线看| 欧美日韩亚洲综合一区二区三区_| 丰满迷人的少妇在线观看| 国产又爽黄色视频| 精品熟女少妇八av免费久了| 国产精品久久久久久精品古装| 大陆偷拍与自拍| 老鸭窝网址在线观看| 麻豆av在线久日| 中文字幕最新亚洲高清| 老司机在亚洲福利影院| 亚洲国产精品国产精品| 免费在线观看完整版高清| 高清黄色对白视频在线免费看| 又大又黄又爽视频免费| 久久国产精品人妻蜜桃| 国产亚洲av高清不卡| 久久亚洲国产成人精品v| 视频在线观看一区二区三区| 亚洲国产精品一区三区| 免费在线观看影片大全网站 | 亚洲av日韩在线播放| 亚洲成人手机| 性高湖久久久久久久久免费观看| 亚洲 欧美一区二区三区| 国产精品国产av在线观看| 精品久久蜜臀av无| 日本五十路高清| 只有这里有精品99| 国产精品熟女久久久久浪| 视频区欧美日本亚洲| 亚洲国产精品一区三区| 91麻豆精品激情在线观看国产 | 少妇猛男粗大的猛烈进出视频| a级片在线免费高清观看视频| 精品久久蜜臀av无| 涩涩av久久男人的天堂| 精品熟女少妇八av免费久了| 国产精品一二三区在线看| 人成视频在线观看免费观看| 老司机深夜福利视频在线观看 | 女人精品久久久久毛片| 亚洲 国产 在线| 如日韩欧美国产精品一区二区三区| 五月天丁香电影| 国产男女超爽视频在线观看| 丝袜美足系列| 成人免费观看视频高清| 国精品久久久久久国模美| 少妇精品久久久久久久| 91精品三级在线观看| 久久久国产精品麻豆| 一本色道久久久久久精品综合| 中文欧美无线码| 国产精品.久久久| 午夜老司机福利片| 中文字幕高清在线视频| 久久国产精品男人的天堂亚洲| 久久人妻熟女aⅴ| 精品欧美一区二区三区在线| 亚洲精品日本国产第一区| 亚洲 国产 在线| 欧美日本中文国产一区发布| 十八禁人妻一区二区| 精品亚洲成国产av| 欧美激情极品国产一区二区三区| 午夜av观看不卡| 真人做人爱边吃奶动态| 丝袜喷水一区| 汤姆久久久久久久影院中文字幕| 黄色毛片三级朝国网站| 国产精品久久久av美女十八| 免费人妻精品一区二区三区视频| 国产片内射在线| 国产视频一区二区在线看| 精品一品国产午夜福利视频| 一区在线观看完整版| 99久久99久久久精品蜜桃| 亚洲国产精品国产精品| 蜜桃国产av成人99| 亚洲,欧美精品.| 亚洲一卡2卡3卡4卡5卡精品中文| 国产成人a∨麻豆精品| 纯流量卡能插随身wifi吗| 深夜精品福利| 国产国语露脸激情在线看| 日本av手机在线免费观看| 日本五十路高清| 一级,二级,三级黄色视频| 丁香六月欧美| 在线观看人妻少妇| av福利片在线| 天天躁夜夜躁狠狠躁躁| bbb黄色大片| 久久久久久久国产电影| 欧美日韩一级在线毛片| 欧美亚洲日本最大视频资源| 香蕉国产在线看| 精品国产超薄肉色丝袜足j| 大香蕉久久成人网| 丝袜在线中文字幕| 国产国语露脸激情在线看| 91字幕亚洲| 国产精品偷伦视频观看了| 午夜激情av网站| 午夜91福利影院| av电影中文网址| 一边摸一边抽搐一进一出视频| 精品亚洲成a人片在线观看| 深夜精品福利| 婷婷色综合大香蕉| 美女国产高潮福利片在线看| 免费看不卡的av| 亚洲精品成人av观看孕妇| 丝袜在线中文字幕| 国产精品久久久人人做人人爽| 汤姆久久久久久久影院中文字幕| 啦啦啦中文免费视频观看日本| 无遮挡黄片免费观看| 国产黄色免费在线视频| 亚洲国产欧美网| 亚洲精品一区蜜桃| 麻豆av在线久日| 亚洲中文日韩欧美视频| 精品人妻在线不人妻| 婷婷色综合大香蕉| 亚洲av在线观看美女高潮| 99久久精品国产亚洲精品| 亚洲少妇的诱惑av| 成人三级做爰电影| 亚洲视频免费观看视频| 久久国产精品人妻蜜桃| 九草在线视频观看| 女人爽到高潮嗷嗷叫在线视频| 成在线人永久免费视频| 亚洲精品日本国产第一区| av网站免费在线观看视频| a 毛片基地| 日韩av在线免费看完整版不卡| 欧美成人午夜精品| 美女主播在线视频| 极品少妇高潮喷水抽搐| 狂野欧美激情性xxxx| 免费少妇av软件| www.精华液| 考比视频在线观看| 久久久久久久精品精品| 老司机影院毛片| 无限看片的www在线观看| 国产亚洲精品久久久久5区| 老司机影院成人| 高清黄色对白视频在线免费看| 97人妻天天添夜夜摸| 最新的欧美精品一区二区| 啦啦啦啦在线视频资源| 国产成人一区二区三区免费视频网站 | 亚洲精品自拍成人| 超碰97精品在线观看| 国产精品九九99| 国产高清videossex| 午夜福利一区二区在线看| 啦啦啦在线观看免费高清www| 国产日韩欧美亚洲二区| 波多野结衣一区麻豆| 国产老妇伦熟女老妇高清| 岛国毛片在线播放| 久久天堂一区二区三区四区| 18在线观看网站| 女人爽到高潮嗷嗷叫在线视频| 欧美变态另类bdsm刘玥| av片东京热男人的天堂| 亚洲精品成人av观看孕妇| 老司机影院毛片| 亚洲国产精品一区三区| 亚洲成人免费av在线播放| 欧美日韩一级在线毛片| 国产亚洲av高清不卡| 大型av网站在线播放| 好男人视频免费观看在线| 欧美激情高清一区二区三区| 97人妻天天添夜夜摸| 大香蕉久久成人网| 亚洲图色成人| 亚洲综合色网址| 考比视频在线观看| 亚洲色图综合在线观看| 色网站视频免费| 国产片特级美女逼逼视频| 电影成人av| 久久久久久免费高清国产稀缺| 欧美日韩一级在线毛片| 午夜福利视频在线观看免费| 国产片内射在线| 亚洲精品美女久久av网站| 美女福利国产在线| 男女下面插进去视频免费观看| 亚洲欧美精品综合一区二区三区| 成人黄色视频免费在线看| 91字幕亚洲| 大码成人一级视频| 国产伦理片在线播放av一区| 亚洲中文日韩欧美视频| 永久免费av网站大全| 国产亚洲一区二区精品| 少妇人妻久久综合中文| 日韩电影二区| xxxhd国产人妻xxx| 狠狠婷婷综合久久久久久88av| 午夜激情av网站| 国产一区二区三区av在线| 国产在线一区二区三区精| xxx大片免费视频| a级片在线免费高清观看视频| 狂野欧美激情性xxxx| 久久久久久久国产电影| 免费女性裸体啪啪无遮挡网站| av在线播放精品| 亚洲成人国产一区在线观看 | 波多野结衣一区麻豆| 久久久久久久精品精品| 精品视频人人做人人爽| 少妇的丰满在线观看| 黄色视频在线播放观看不卡| 校园人妻丝袜中文字幕| h视频一区二区三区| 亚洲欧洲国产日韩| 免费看av在线观看网站| 汤姆久久久久久久影院中文字幕| 亚洲欧美精品综合一区二区三区| 亚洲国产精品一区二区三区在线| 又黄又粗又硬又大视频| 黄色一级大片看看| 人人妻人人添人人爽欧美一区卜| 宅男免费午夜| 多毛熟女@视频| 在线观看免费视频网站a站| 国产97色在线日韩免费| 日本五十路高清| 少妇人妻 视频| 18禁观看日本| 国产一区二区三区av在线| 亚洲专区国产一区二区| 天堂中文最新版在线下载| 天天躁日日躁夜夜躁夜夜| 国产在线免费精品| 久久99热这里只频精品6学生| 1024香蕉在线观看| 男女国产视频网站| 两个人免费观看高清视频| 一边亲一边摸免费视频| 91成人精品电影| 国产97色在线日韩免费| 男人舔女人的私密视频| 国产熟女午夜一区二区三区| 天堂俺去俺来也www色官网| 亚洲av国产av综合av卡| 午夜激情av网站| 大型av网站在线播放| 在现免费观看毛片| 性色av乱码一区二区三区2| 一区二区三区乱码不卡18| 精品久久久久久久毛片微露脸 | 亚洲精品自拍成人| 九色亚洲精品在线播放| 国产成人精品久久久久久| 欧美日韩国产mv在线观看视频| 国产一区二区激情短视频 | 久久精品国产综合久久久| 亚洲av日韩精品久久久久久密 | 久久久久久久大尺度免费视频| 亚洲色图 男人天堂 中文字幕| 一级a爱视频在线免费观看| 亚洲激情五月婷婷啪啪| 国产片特级美女逼逼视频| 免费女性裸体啪啪无遮挡网站| 99九九在线精品视频| 国产男女超爽视频在线观看| 午夜日韩欧美国产| 国产熟女欧美一区二区| 超碰成人久久| 日韩一本色道免费dvd| 一区二区三区激情视频| 午夜福利乱码中文字幕| 亚洲精品日韩在线中文字幕| 欧美精品亚洲一区二区| 国产有黄有色有爽视频| 日韩人妻精品一区2区三区| 日韩免费高清中文字幕av| 丝袜美腿诱惑在线| 国语对白做爰xxxⅹ性视频网站| 国产一区二区激情短视频 | 国产精品秋霞免费鲁丝片| 91字幕亚洲| 操美女的视频在线观看| 精品欧美一区二区三区在线| 丰满饥渴人妻一区二区三| 在线观看免费日韩欧美大片| 精品国产超薄肉色丝袜足j| 青草久久国产| 悠悠久久av| 别揉我奶头~嗯~啊~动态视频 | 曰老女人黄片| 天天躁夜夜躁狠狠久久av| 欧美国产精品va在线观看不卡| 51午夜福利影视在线观看| 不卡av一区二区三区| 亚洲国产欧美一区二区综合| 黄色视频在线播放观看不卡| 亚洲男人天堂网一区| 一区二区三区精品91| 日韩av免费高清视频| 日韩视频在线欧美| 777米奇影视久久| 免费少妇av软件| 成人三级做爰电影| av视频免费观看在线观看| 久久久精品94久久精品| 国产精品国产av在线观看| 青春草亚洲视频在线观看| 精品少妇黑人巨大在线播放| 亚洲精品av麻豆狂野| 国产欧美日韩精品亚洲av| 啦啦啦在线免费观看视频4| 亚洲av日韩精品久久久久久密 | 国产成人a∨麻豆精品| 老司机影院毛片| 色播在线永久视频| 国产有黄有色有爽视频| 老司机影院成人| 亚洲精品自拍成人| 一二三四在线观看免费中文在| 国产精品 国内视频| 天堂俺去俺来也www色官网| 久9热在线精品视频| 欧美+亚洲+日韩+国产| 亚洲成国产人片在线观看| 男人添女人高潮全过程视频| 丰满人妻熟妇乱又伦精品不卡| 欧美黑人欧美精品刺激| 脱女人内裤的视频| 国产成人精品在线电影| 一本久久精品| 纵有疾风起免费观看全集完整版| 狂野欧美激情性bbbbbb| 国产成人影院久久av| 悠悠久久av| 精品一区二区三区四区五区乱码 | 亚洲人成77777在线视频| 欧美人与性动交α欧美软件| 永久免费av网站大全| 国产亚洲av高清不卡| 精品熟女少妇八av免费久了| 伊人久久大香线蕉亚洲五| 国产一区亚洲一区在线观看| 日韩精品免费视频一区二区三区| 亚洲av电影在线观看一区二区三区|